Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4921471 | 0.90 | DGAT1 (0.73) | DGAT1CNR1 | |
| SCHEMBL4883194 | 0.87 | DGAT1 (1.00) | DGAT1 | |
| SCHEMBL4916343 | 0.86 | DGAT1 (0.78) | DGAT1 | |
| SCHEMBL4890892 | 0.85 | DGAT1 (0.96) | DGAT1 | |
| SCHEMBL4924530 | 0.80 | DGAT1 (0.58) | DGAT1CNR1 | |
| SCHEMBL4921498 | 0.80 | DGAT1 (0.78) | DGAT1 | |
| SCHEMBL4920050 | 0.79 | DGAT1 (0.84) | DGAT1 | |
| SCHEMBL4921516 | 0.77 | DGAT1 (0.63) | DGAT1CNR1 | |
| SCHEMBL4925841 | 0.76 | DGAT1 (0.68) | DGAT1 | |
| SCHEMBL4925846 | 0.76 | DGAT1 (0.68) | DGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080064717-A1 | Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme | ABBOTT LABORATORIES | 2008-03-13 | — | — | US | claimed |
| US-20080064717-A1 | Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme | ABBOTT LABORATORIES | 2008-03-13 | — | — | US | disclosed |
| WO-2007137107-A2 | INHIBITORS OF DIACYLGLYCEROL O-ACYLTRANSFERASE TYPE 1 ENZYME | ABBOTT LABORATORIES (US) | 2007-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064717-A1 | Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme | DGAT1, DGAT2, DLAT | DGAT1 1/4885CNR1 1268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.